Home > Pressrelease > Compression Therapy Market size to exceed $4Bn by 2032

Compression Therapy Market size to exceed $4Bn by 2032

  • Published Date: March 31, 2023

Compression Therapy Market value is set to reach over USD 4 billion by 2032, as per a new research report announced by Global Market Insights Inc.

Compression treatments are becoming more popular owing to increasing patient awareness of the available treatment alternatives. Moreover, supportive government initiatives to simplify product approval procedures, as well as continuous efforts to provide reimbursement policies for medical expenditures associated with the treatment of various orthopedic therapies, venous disorders, lymphedema, and other similar conditions, are likely to drive market development through 2032.

Rise in sports and road accident injuries to boost compression braces segment

Compression therapy market share from the compression braces segment to expand at around 5.5% CAGR  by 2032. Compression braces are often used for recovery post joint injuries or surgeries of the knee, elbow, and ankle. Compression braces are gaining traction due to an increase in sports and road accident injuries. The growing use of compression treatment owing to the beneficial product characteristics, such as their low cost, ability to be applied easily, and suitability for a wide variety of clinical performances is anticipated to support segment expansion by 2032.

Browse key industry insights spread across 250 pages with 410 market data tables & 15 figures & charts from the report, Compression Therapy Market Size By Product (Compression Garments {Compression Bandages, Compression Stockings [Compression Class I, Compression Class II, Compression Class III]}, Compression Braces, Compression Tapes, Compression Pumps), By Technology (Static Compression Therapy, Dynamic Compression Therapy), By Application (Varicose Vein Treatment, Deep Vein Thrombosis Treatment, Lymphedema Treatment, Leg Ulcer Treatment), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:

Rising need for speedy athlete recovery to promote dynamic compression therapy segment demand

Dynamic compression therapy industry is likely to to grow at a 6% growth rate  by 2032 owing to the upsurge in the number of hip replacement surgeries worldwide to lower the risk of postoperative deep vein thrombosis. In addition, highly skilled athletes undergo rigorous training that causes muscle microtrauma and exercise-induced inflammation. Dynamic compression treatments aid in managing edema, increased blood flow, enhanced lymphatic return, and pain relief. Various scientific and medical fields have begun to collaborate in athlete recovery, including physical therapy, athletic training, massage treatment, and nutrition, which is slated to accelerate segment progression through 2032.

High prevalence of lymphedema among cancer patients to favor the lymphedema treatment segment

Compression therapy market revenue from the lymphedema treatment segment is estimated to garner USD 634 million by 2032 owing to the prevalence of lymphedema among cancer patients undergoing radiation, chemotherapy, or other medical conditions. Furthermore, ongoing R&D activities to introduce novel and effective products for lymphedema treatment are estimated to complement segment progression.

Surging geriatric population to contribute to the Asia Pacific industry

Asia Pacific compression therapy market is poised to generate a valuation of over USD 1 billion by 2032. The regional industry expansion is attributed to the expanding geriatric population suffering from orthopedic conditions, and the growing awareness about the development of advanced treatment facilities. Additionally, the availability of facilitative reimbursement plans is anticipated to augment industry progress in the region. Moreover, the high prevalence of venous conditions across the major APAC countries is projected to drive regional market landscape through 2032.

Introduction of novel products to define the industry outlook

3M Company, Arjohuntleigh, Paul Hartmann AG, Cardinal Health, Inc., BIO Compression Systems, Inc., Alcare Company Ltd., Convatech, Inc., Smith & Nephew Plc., DJO Global Inc. (Colfax Corporation), Essity, Julius Zorn GmbH, Medi GmbH & Co. KG, Sanyleg S.R.L., Tactile Medical, and Sigvaris.

Authors: Rupali Swain, Subodh Kharad